As of 2025-08-11, the Relative Valuation of Avidity Biosciences Inc (RNA) is (74.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.29 USD, the upside of Avidity Biosciences Inc based on Relative Valuation is -260.8%.
The range of the Relative Valuation is (52.53) - (90.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 23.4x | 18.5x |
| Forward P/E multiples | 13.5x - 26.6x | 20.0x |
| Fair Price | (52.53) - (90.38) | (74.45) |
| Upside | -213.5% - -295.3% | -260.8% |
| Date | P/E |
| 2025-08-06 | -12.49 |
| 2025-08-05 | -9.91 |
| 2025-08-04 | -9.67 |
| 2025-08-01 | -9.30 |
| 2025-07-31 | -9.50 |
| 2025-07-30 | -9.55 |
| 2025-07-29 | -9.31 |
| 2025-07-28 | -8.95 |
| 2025-07-25 | -9.39 |
| 2025-07-24 | -8.60 |
| 2025-07-23 | -8.78 |
| 2025-07-22 | -8.68 |
| 2025-07-21 | -8.81 |
| 2025-07-18 | -8.74 |
| 2025-07-17 | -8.81 |
| 2025-07-16 | -8.68 |
| 2025-07-15 | -8.21 |
| 2025-07-14 | -8.69 |
| 2025-07-11 | -8.14 |
| 2025-07-10 | -8.15 |
| 2025-07-09 | -8.10 |
| 2025-07-08 | -7.57 |
| 2025-07-07 | -7.46 |
| 2025-07-03 | -7.55 |
| 2025-07-02 | -7.60 |
| 2025-07-01 | -7.37 |
| 2025-06-30 | -7.35 |
| 2025-06-27 | -7.52 |
| 2025-06-26 | -7.72 |
| 2025-06-25 | -7.74 |
| 2025-06-24 | -7.73 |
| 2025-06-23 | -7.55 |
| 2025-06-20 | -7.59 |
| 2025-06-18 | -7.59 |
| 2025-06-17 | -7.60 |
| 2025-06-16 | -7.72 |
| 2025-06-13 | -8.12 |
| 2025-06-12 | -8.32 |
| 2025-06-11 | -8.29 |
| 2025-06-10 | -8.70 |
| 2025-06-09 | -8.46 |
| 2025-06-06 | -9.38 |
| 2025-06-05 | -9.21 |
| 2025-06-04 | -8.86 |
| 2025-06-03 | -8.91 |
| 2025-06-02 | -8.59 |
| 2025-05-30 | -8.02 |
| 2025-05-29 | -8.21 |
| 2025-05-28 | -8.00 |
| 2025-05-27 | -7.86 |